低分子肝素钙对肺源性心脏病并呼吸衰竭的临床效果分析(1)
[摘要] 目的 探讨低分子肝素钙对肺源性心脏病并呼吸衰竭患者的临床疗效。 方法 选择2011年1月～2013年1月本院收治的82例肺源性心脏病并呼吸衰竭患者为研究对象，根据临床治疗方式的不同将其分为观察组与对照组，每组41例，对照组患者给予常规治疗，观察组患者在对照组的基础上给予低分子肝素钙治疗，比较两组患者的治疗效果。 结果 观察组患者的治疗效果明显好于对照组(P<0.05)；观察组患者的PaO2、PaCO2、PT与APTT的情况明显优于对照组，差异有统计学意义(P<0.05)。 结论 低分子肝素钙对肺源性心脏病并呼吸衰竭患者的临床疗效显著，能有效改善患者的心肺功能和通气情况，降低死亡率，提高患者的生存质量，具有较高的临床应用价值。
[关键词] 低分子肝素钙；肺心病；呼吸衰竭
[中图分类号] R541.5 [文献标识码] A [文章编号] 1674-4721(2015)06(c)-0079-03
[Abstract] Objective To evaluate the clinical efficacy of low molecular weight heparin on pulmonary heart disease associated with respiratory failure. Methods Eighty-two patients with pulmonary heart disease associated with respiratory failure treated in our hospital from January 2011 to January 2013 were selected as the study subjects and divided into observation group and control group according to the clinical treatment method ......
您现在查看是摘要页，全文长 3423 字符。
[关键词] 低分子肝素钙；肺心病；呼吸衰竭
[中图分类号] R541.5 [文献标识码] A [文章编号] 1674-4721(2015)06(c)-0079-03
[Abstract] Objective To evaluate the clinical efficacy of low molecular weight heparin on pulmonary heart disease associated with respiratory failure. Methods Eighty-two patients with pulmonary heart disease associated with respiratory failure treated in our hospital from January 2011 to January 2013 were selected as the study subjects and divided into observation group and control group according to the clinical treatment method ......
您现在查看是摘要页，全文长 3423 字符。